PacBio en­gi­neers $800M buy­out of se­quenc­ing ri­val Om­niome as an­a­lysts fret over FTC ac­tion

As Il­lu­mi­na runs in­to an­oth­er reg­u­la­to­ry road­block to ex­pan­sion, one of its al­most-sub­sidiaries is charg­ing ahead with a new buy­out.

Pa­cif­ic Bio­sciences, of­ten re­ferred …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.